2 years ago
KRYS
AnalystsMadhu KumarMadhu Kumar's Stock Forecasts
AnalystsMadhu Kumar
Analyst Ranking
Top 3%
#123 out of 4937 analysts
Average Return
+34.62%
Win Rate
57%56 out of 99
Risk vs Reward
Poor
Good
Madhu Kumar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gyre Therapeutics IncGYRE | +450.00% | $65.70 | $361.35 | 2017-06-12 - 2018-06-12 | Strong Buy |
Reata Pharmaceuticals IncRETA | +351.20% | $38.20 | $172.36 | 2022-11-28 - 2023-09-25 | Strong Buy |
Reata Pharmaceuticals IncRETA | +350.38% | $38.27 | $172.36 | 2022-11-09 - 2023-09-25 | Strong Buy |
Scholar Rock Holding CorpSRRK | +331.26% | $14.97 | $64.56 | 2020-03-12 - 2021-03-12 | Buy |
Arbutus Biopharma CorpABUS | +309.92% | $1.21 | $4.96 | 2020-03-27 - 2020-07-24 | Buy |
Madhu Kumar Analyst Color
Get additional color on Madhu Kumar's coverage of popular stocks
3 years ago
ARWR
4 years ago
DNTH
Madhu Kumar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Jazz Pharmaceuticals PLCJAZZ | 7 | Strong Buy | $169.00 | N/A | Initiates Coverage On | a year ago |
Fulcrum Therapeutics IncFULC | 8 | Hold | $6.00 | N/A | Maintains | a year ago |
Informatica IncINFA | 5 | Hold | $26.00 | N/A | Maintains | 2 years ago |
Utz Brands IncUTZ | 2 | Hold | $17.00 | N/A | Maintains | 2 years ago |
Alector IncALEC | 2 | Strong Sell | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 4 | Hold | $30.00 | N/A | Maintains | 2 years ago |
Krystal Biotech IncKRYS | 11 | Strong Buy | $155.00 | N/A | Maintains | 2 years ago |
Cytokinetics IncCYTK | 4 | Strong Buy | $53.00 | N/A | Maintains | 2 years ago |
Arrowhead Pharmaceuticals IncARWR | 7 | Strong Buy | $73.00 | N/A | Maintains | 2 years ago |
Apellis Pharmaceuticals IncAPLS | 7 | Strong Buy | $141.00 | N/A | Maintains | 2 years ago |
Syndax Pharmaceuticals IncSNDX | 5 | Strong Buy | $34.00 | N/A | Maintains | 2 years ago |
Reata Pharmaceuticals IncRETA | 6 | Strong Buy | $185.00 | N/A | Maintains | 2 years ago |
Iovance Biotherapeutics IncIOVA | 4 | Hold | $6.00 | N/A | Downgrades | 3 years ago |
Arcturus Therapeutics Holdings IncARCT | 4 | Strong Sell | $14.00 | N/A | Maintains | 3 years ago |
Dynavax Technologies CorpDVAX | 2 | Strong Buy | $21.00 | N/A | Maintains | 3 years ago |
Cincor Pharma IncCINC | 1 | Strong Buy | $67.00 | N/A | Initiates Coverage On | 3 years ago |
Edgewise Therapeutics IncEWTX | 2 | Strong Sell | $5.00 | N/A | Downgrades | 3 years ago |
Dianthus Therapeutics IncDNTH | 2 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 2 | Strong Buy | $144.00 | N/A | Maintains | 3 years ago |
Myovant Sciences LtdMYOV | 1 | Hold | $10.00 | N/A | Maintains | 3 years ago |
Tricida IncTCDAQ | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Passage Bio IncPASG | 1 | Hold | $6.00 | N/A | Downgrades | 3 years ago |
Design Therapeutics IncDSGN | 1 | Strong Sell | $10.00 | N/A | Initiates Coverage On | 3 years ago |
Arvinas IncARVN | 1 | Strong Buy | $157.00 | N/A | Initiates Coverage On | 3 years ago |
Applied Therapeutics IncAPLT | 1 | Strong Sell | $10.00 | N/A | Downgrades | 4 years ago |
Dicerna Pharmaceuticals IncDRNA | 5 | Hold | $25.00 | N/A | Downgrades | 4 years ago |
Intellia Therapeutics IncNTLA | 5 | Hold | $85.00 | N/A | Maintains | 4 years ago |
Editas Medicine IncEDIT | 3 | Strong Sell | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Cellectis SaCLLS | 2 | Buy | $39.00 | N/A | Upgrades | 4 years ago |
Gritstone Bio IncGRTSQ | 1 | Sell | $8.00 | N/A | Downgrades | 4 years ago |
Cellular Biomedicine Group IncCBMG | 2 | Hold | $19.00 | N/A | Downgrades | 5 years ago |
Uniqure NvQURE | 2 | Buy | $57.00 | N/A | Upgrades | 5 years ago |
Arbutus Biopharma CorpABUS | 8 | Hold | N/A | N/A | Downgrades | 5 years ago |
Aprea Therapeutics IncAPRE | 1 | Buy | $900.00 | N/A | Initiates Coverage On | 5 years ago |
Vir Biotechnology IncVIR | 1 | Sell | $20.00 | N/A | Maintains | 5 years ago |
Palvella Therapeutics IncPVLA | 3 | Buy | $400.00 | N/A | Upgrades | 5 years ago |
Akari Therapeutics PLCAKTX | 4 | Strong Buy | $100.00 | N/A | Maintains | 5 years ago |
Scholar Rock Holding CorpSRRK | 1 | Buy | $35.00 | N/A | Initiates Coverage On | 5 years ago |
Leap Therapeutics IncLPTX | 1 | Buy | $60.00 | N/A | Initiates Coverage On | 5 years ago |
Eyepoint Pharmaceuticals IncEYPT | 2 | Strong Buy | $40.00 | N/A | Maintains | 6 years ago |
Spark Therapeutics IncONCE | 1 | Strong Buy | $71.00 | N/A | Upgrades | 7 years ago |
Assembly Biosciences IncASMB | 3 | Strong Buy | $504.00 | N/A | Upgrades | 7 years ago |
Tetraphase Pharmaceuticals IncTTPH | 1 | Strong Buy | $7.00 | N/A | Maintains | 7 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $55.00 | N/A | Maintains | 7 years ago |
Clementia Pharmaceuticals IncCMTA | 2 | Strong Buy | $16.00 | N/A | Maintains | 7 years ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $230.00 | N/A | Maintains | 7 years ago |
Regulus Therapeutics IncRGLS | 4 | Hold | $60.00 | N/A | Maintains | 7 years ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Gyre Therapeutics IncGYRE | 2 | Strong Buy | $1,125.00 | N/A | Maintains | 7 years ago |
Inflarx NvIFRX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 7 years ago |
Achillion Pharmaceuticals IncACHN | 1 | Hold | $3.50 | N/A | Initiates Coverage On | 7 years ago |
Tg Therapeutics IncTGTX | 1 | Strong Buy | $21.50 | N/A | Reinstates | 8 years ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $23.50 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.